Abstract:objeCtives: Approximately 483 patients in Slovakia are living with HIV, with 68 new infections in 2013. Raltegravir (RAL) is reimbursed for HIV-1-infected treatmentnaive (TN) and treatment-experienced (TE) patients in Slovakia. The objective of this analysis was to determine the cost-effectiveness of dolutegravir (DTG) relative to RAL. Methods: This study is based on the Anti-Retroviral Analysis by Monte Carlo Individual Simulation model. A microsimulation approach simulates the outcome of anti-retroviral ther… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.